M&A Update – March 15

– JNCE received unsolicited proposal from Concentra Biosciences at $1.80 cash per share + CVR
– ATC.to / HL extended letter of intent
– AAWW / Apollo / J.F. Lehman / Hill City Capital satisfied all regulatory approvals, closing Mar 17
– MRV.to / Searchlight Pharma deal closed
– IAA / RBA shareholders approved merger, all stockholder and regulatory approvals obtained, closing Mar 20
– APE / AMC shareholders approved share consolidation and preferred shares conversion (>87% vote FOR including >70% AMC shareholders voting FOR)
– ATVI / MSFT signed 10-year agreement to bring Call of Duty to Boosteroid